Emerging tendency towards autoimmune process in major depressive patients: A novel insight from Th17 cells

Psychiatry Research

Volumn 188, Issue 2, 2011, Pages 224-230

  Chen, Yili ^a   Jiang, Tang ^a   Chen, Peisong ^a   Ouyang, Juan ^a   Xu, Guiyun ^b   Zeng, Zhijie ^a   Sun, Yanhong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b Psychiatric Institute of Mental Health Hospital   (China)

Author keywords

Autoimmune process; Major depressive disorder; Th17 cells

Indexed keywords

ANTINUCLEAR ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RETINOID RELATED ORPHAN RECEPTOR GAMMA T; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; TH17 CELL;

ADULT; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNITY; DEPRESSIVE DISORDER, MAJOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PSYCHIATRIC STATUS RATING SCALES; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TH17 CELLS; YOUNG ADULT;

EID: 79958290000     PISSN: 01651781     EISSN: 01651781     Source Type: Journal    
DOI: 10.1016/j.psychres.2010.10.029     Document Type: Article

References (48)

1. Afzali B., Lombardi G., Lechler R.I., Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clinical and Experimental Immunology 2007, 148(1):32-46.
2. Amoroso A., Mitterhofer A.P., Ferri G.M., Galluzzo S., Vadacca M., Afeltra A. Neurological involvement in antiphospholipid antibodies syndrome (APS). European Review for Medical and Pharmacological Sciences 1999, 3:205-209.
3. Awasthi A., Murugaiyan G., Kuchroo V.K. Interplay Between Effector Th17 and Regulatory T Cells. Journal of Clinical Immunology 2008, 28:660-670.
4. Bagnato G., De Filippis L.G., Caliri A., Bruno A., Gambardella N., Muscatello M.R., Cambria R., Zoccali R. Comparation of levels of anxiety and depression in patients with autoimmune and chronic-degenerative rheumatic: preliminary data. Reumatismo 2006, 58:206-211.
5. Bettelli E., Carrier Y.J., Gao W.D., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector T(H)17 and regulatory T cells. Nature 2006, 441:235-238.
6. Chen P., Jiang T., Ouyang J., Chen Y. Depression, another autoimmune disease from the view of autoantibodies. Medical Hypotheses 2009, 73:508-509.
7. Dickens C., McGowan L., Clark-Carter D., Creed F. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosomatic Medicine 2002, 64:52-60.
8. Dinan T.G. Inflammatory markers in depression. Current Opinion in Psychiatry 2009, 22:32-36.
9. Eisenstein E.M., Williams C.B. The T-reg/Th17 Cell Balance: A New Paradigm for Autoimmunity. Pediatric Research 2009, 65:26r-31r.
10. Fountoulakis K.N., Iacovides A., Grammaticos P., St Kaprinis G., Bech P. Thyroid function in clinical subtypes of major depression: an exploratory study. BMC Psychiatry 2004, 4:6.
11. Gabbay V., Klein R.G., Alonso C.M., Babb J.S., Nishawala M., De Jesus G., Hirsch G.S., Hottinger-Blanc P.M., Gonzalez C.J. Immune system dysregulation in adolescent major depressive disorder. Journal of Affective Disorders 2009, 115:177-182.
12. Hofstetter H., Gold R., Hartung H.P. Th17 Cells in MS and Experimental Autoimmune Encephalomyelitis. International MS Journal 2009, 16:12-18.
13. Hsu H.C., Yang P., Wang J., Wu Q., Myers R., Chen J., Yi J., Guentert T., Tousson A., Stanus A.L., Le T.V., Lorenz R.G., Xu H., Kolls J.K., Carter R.H., Chaplin D.D., Williams R.W., Mountz J.D. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nature Immunology 2008, 9:166-175.
14. Huizinga T.W., Diamond B. Lupus and the central nervous system. Lupus 2008, 17:376-379.
15. Irwin M.R., Miller A.H. Depressive disorders and immunity: 20years of progress and discovery. Brain, Behavior, and Immunity 2007, 21:374-383.
16. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
17. Iwakura Y., Ishigame H. The IL-23/IL-17 axis in inflammation. The Journal of Clinical Investigation 2006, 116:1218-1222.
18. Jara L.J., Navarro C., Medina G., Vera-Lastra O., Blanco F. Immune-neuroendocrine interactions and autoimmune diseases. Clinical and Development Immunology 2006, 13:109-123.
19. Katzav A., Solodeev I., Brodsky O., Chapman J., Pick C.G., Blank M., Zhang W., Reichlin M., Shoenfeld Y. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis and Rheumatism 2007, 56:938-948.
20. Kawanokuchi J., Shimizu K., Nitta A., Yamada K., Mizuno T., Takeuchi H., Suzumura A. Production and functions of IL-17 in microglia. Journal of Neuroimmunology 2008, 194:54-61.
21. Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., Giuliani F., Arbour N., Becher B., Prat A. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Natural Medicines 2007, 13:1173-1175.
22. Kim Y.K., Lee S.W., Kim S.H., Shim S.H., Han S.W., Choi S.H., Lee B.H. Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Progress in Neuropsychopharmacology & Biological Psychiatry 2008, 32:356-361.
23. Kolls J.K., Linden A. Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476.
24. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. Journal of Immunology 2006, 177:566-573.
25. Korn T., Oukka M., Kuchroo V., Bettelli E. Th17 cells: effector T cells with inflammatory properties. Seminars in Immunology 2007, 19:362-371.
26. Kuijpens J.L., Vader H.L., Drexhage H.A., Wiersinga W.M., van Son M.J., Pop V.J. Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum. European Journal of Endocrinology 2001, 145:579-584.
27. Laske C., Zank M., Klein R., Stransky E., Batra A., Buchkremer G., Schott K. Autoantibody reactivity in serum of patients with major depression, schizophrenia and healthy controls. Psychiatry Research 2008, 158:83-86.
28. Lewitus G.M., Wilf-Yarkoni A., Ziv Y., Shabat-Simon M., Gersner R., Zangen A., Schwartz M. Vaccination as a Novel Approach for Treating Depressive Behavior. Biological Psychiatry 2009, 65:283-288.
29. Li Y., Xiao B., Qiu W., Yang L., Hu B., Tian X., Yang H. Altered expression of CD4(+)CD25(+) regulatory T cells and its 5-HT(1a) receptor in patients with major depression disorder. Journal of Affective Disorders 2009, 124:68-75.
30. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Natural Medicines 2002, 8:500-508.
31. Maes M., Bosmans E., Suy E., Vandervorst C., Dejonckheere C., Raus J. Antiphospholipid, antinuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients. Journal of Affective Disorders 1991, 21:133-140.
32. Maes M., Meltzer H., Jacobs J., Suy E., Calabrese J., Minner B., Raus J. Autoimmunity in depression: increased antiphospholipid autoantibodies. Acta Psychiatrica Scandinavica 1993, 87:160-166.
33. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
34. Matusevicius D., Kivisakk P., He B., Kostulas N., Ozenci V., Fredrikson S., Link H. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Multiple Sclerosis 1999, 5:101-104.
35. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., Cua D.J. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nature Immunology 2007, 8:1390-1397.
36. Myint A.M., Leonard B.E., Steinbusch H.W., Kim Y.K. Th1, Th2, and Th3 cytokine alterations in major depression. Journal of Affective Disorders 2005, 88:167-173.
37. O'Garra A., Stockinger B., Veldhoen M. Differentiation of human T(H)-17 cells does require TGF-beta!. Nature Immunology 2008, 9:588-590.
38. Shoenfeld Y. To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system. Journal of Autoimmunity 2007, 28:165-169.
39. Sluzewska A., Rybakowski J., Bosmans E., Sobieska M., Berghmans R., Maes M., Wiktorowicz K. Indicators of immune activation in major depression. Psychiatry Research 1996, 64:161-167.
40. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Natural Medicines 2007, 13:139-145.
41. Stockinger B., Veldhoen M. Differentiation and function of Th17 T cells. Current Opinion in Immunology 2007, 19:281-286.
42. Stockinger B., Veldhoen M., Martin B. Th17 T cells: linking innate and adaptive immunity. Seminars in Immunology 2007, 19:353-361.
43. Stromnes I.M., Cerretti L.M., Liggitt D., Harris R.A., Goverman J.M. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Natural Medicines 2008, 14:337-342.
44. Sutcigil L., Oktenli C., Musabak U., Bozkurt A., Cansever A., Uzun O., Sanisoglu S.Y., Yesilova Z., Ozmenler N., Ozsahin A., Sengul A. Pro- and anti-inflammatory cytokine balance in major depression: Effect of sertraline therapy. Clinical & Developmental Immunology 2007, 11:152.
45. Vojdani, A., Lambert, J., 2009a. The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part I. Evidence-Based Complementary and Alternative Medicine doi:10.1093/ecam/nep062.
46. Vojdani, A., Lambert, J., 2009b. The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II. Evidence-Based Complementary and Alternative Medicine doi:10.1093/ecam/nep063.
47. Yong V.W., Power C., Forsyth P., Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nature Reviews. Neuroscience 2001, 2:502-511.
48. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., Shen Y., Du J., Rubtsov Y.P., Rudensky A.Y., Ziegler S.F., Littman D.R. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240.